News

NHIF: Supporting home infusion

The National Home Infusion Foundation (NHIF) invests in and performs research as well as recognizes and supports outstanding home infusion professionals and their work.

NHIA Community Top Discussions

Review the list of the top discussion topics to gain insight from professionals from around the NHIA Community on the most pertinent and timely issues of the past year. Learn what other infusion providers are considering and jump in to share your perspective as well!

Read More »

New Ways to stay Updated on Community Activity

The NHIA Community provides you several ways to be notified of updates in the community, allowing you to adjust the frequency and format of your notifications. This way you know, on your schedule, when new discussion posts and replies are added or when there is other news or announcements.

Read More »

Celebrating 1 Year of the NHIA Community Platform

The NHIA Community has officially been supporting and connecting our members for one year. Although this is still just the early days of this incredible resource for the home and alternate site infusion industry, we have seen some amazing things during year one and have a lot more planned to continue to improve the platform and what it offers NHIA members.

Read More »

NHIA’s Michelle Simpson Earns Medical Writer Certification

The National Home Infusion Association (NHIA) is pleased to announce that Michelle Simpson has recently earned the credential of Medical Writer Certified (MWC) after successfully completing the rigorous application and examination process developed and administered by the Medical Writing Certification Commission (MWCC) of the American Medical Writers Association (AMWA).

Read More »

Considerations for Addressing ExactaMix Automated Compounding Device (ACD) Valve Set Supply Disruption

On April 19, 2022, Baxter announced a supply disruption of the ExactaMix valve sets (ExactaMix 1200 Valve Set H938792 and ExactaMix 2400 Valve Set H938724) due to raw material constraints that are impacting production volumes. As a result, healthcare providers and institutions are driven to consider conservation measures when compounding using the ExactaMix Automated Compounder.

Read More »

NHIA Releases Comments on California Senate Bill 958

NHIA submitted comments on California SB 958, the Medication and Patient Safety Act of 2022, supporting amendments to the proposed legislation that allow for infused medications to be administered in the enrollee’s home when the physician and patient determine it is in the patient’s best interest and weighing in on various other aspects of the bill.

Read More »

National Home Infusion Foundation Launches Infusion Journal

The National Home Infusion Foundation (NHIF) is proud to announce the publication of the first issue of Infusion Journal. The new scholarly journal features independent research and studies related to infused therapies, patient outcomes, medication safety, economic analyses, and case studies.

Read More »

NHIA Submits Comments on DIR Proposed Rule

NHIA submitted comments on a CMS proposed rule: Medicare and Medicaid Programs; CY 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs, which would alter the way pharmacy price concessions, including direct and indirect remuneration (DIR fees), are calculated by pharmacy benefit managers (PBMs).

Read More »

NHIA Community Top Discussions

Review the list of the top discussion topics to gain insight from professionals from around the NHIA Community on the most pertinent and timely issues of the past year. Learn what other infusion providers are considering and jump in to share your perspective as well!

Read More »

New Ways to stay Updated on Community Activity

The NHIA Community provides you several ways to be notified of updates in the community, allowing you to adjust the frequency and format of your notifications. This way you know, on your schedule, when new discussion posts and replies are added or when there is other news or announcements.

Read More »

Celebrating 1 Year of the NHIA Community Platform

The NHIA Community has officially been supporting and connecting our members for one year. Although this is still just the early days of this incredible resource for the home and alternate site infusion industry, we have seen some amazing things during year one and have a lot more planned to continue to improve the platform and what it offers NHIA members.

Read More »

NHIA’s Michelle Simpson Earns Medical Writer Certification

The National Home Infusion Association (NHIA) is pleased to announce that Michelle Simpson has recently earned the credential of Medical Writer Certified (MWC) after successfully completing the rigorous application and examination process developed and administered by the Medical Writing Certification Commission (MWCC) of the American Medical Writers Association (AMWA).

Read More »

Considerations for Addressing ExactaMix Automated Compounding Device (ACD) Valve Set Supply Disruption

On April 19, 2022, Baxter announced a supply disruption of the ExactaMix valve sets (ExactaMix 1200 Valve Set H938792 and ExactaMix 2400 Valve Set H938724) due to raw material constraints that are impacting production volumes. As a result, healthcare providers and institutions are driven to consider conservation measures when compounding using the ExactaMix Automated Compounder.

Read More »

NHIA Releases Comments on California Senate Bill 958

NHIA submitted comments on California SB 958, the Medication and Patient Safety Act of 2022, supporting amendments to the proposed legislation that allow for infused medications to be administered in the enrollee’s home when the physician and patient determine it is in the patient’s best interest and weighing in on various other aspects of the bill.

Read More »

National Home Infusion Foundation Launches Infusion Journal

The National Home Infusion Foundation (NHIF) is proud to announce the publication of the first issue of Infusion Journal. The new scholarly journal features independent research and studies related to infused therapies, patient outcomes, medication safety, economic analyses, and case studies.

Read More »

NHIA Submits Comments on DIR Proposed Rule

NHIA submitted comments on a CMS proposed rule: Medicare and Medicaid Programs; CY 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs, which would alter the way pharmacy price concessions, including direct and indirect remuneration (DIR fees), are calculated by pharmacy benefit managers (PBMs).

Read More »